Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doxycycline, Temozolomide and Ipilimumab in Melanoma

This study has been terminated.
(Accrual slow due to alternate trials and treatment options.)
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01590082
First received: April 30, 2012
Last updated: November 10, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)